GBWM
ATYR

Granite Bay Wealth Management’s aTyr Pharma ATYR Stock Holding History

Granite Bay Wealth Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,000
Closed -$22K – 302
2023
Q4 		$22K Buy
+18,000
New +$23.1K ﹤0.01% 304

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Granite Bay Wealth Management's ATYR Position: Q1 2024 in Review

Granite Bay Wealth Management sold out of aTyr Pharma (ATYR) in Q1 2024, closing a stake of 18,000 shares — an estimated $22K sold.

Granite Bay Wealth Management first reported a position in ATYR in Q4 2023 and held it in 1 quarter. The position peaked at $22K in Q4 2023. 56 funds tracked by Wall St. Rank hold ATYR as of Q1 2024.

  • Granite Bay Wealth Management reported no remaining aTyr Pharma position as of Q1 2024 after selling out during the quarter.
  • Granite Bay Wealth Management sold 18,000 aTyr Pharma shares in Q1 2024, an estimated $22K.
  • Granite Bay Wealth Management first reported a position in aTyr Pharma in Q4 2023 and held it in 1 quarter.
  • Granite Bay Wealth Management's aTyr Pharma position peaked at $22K in Q4 2023.
  • 56 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2024.

Based on Granite Bay Wealth Management's 13F filing for Q1 2024, filed 30 Apr 2024.